<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02271867</url>
  </required_header>
  <id_info>
    <org_study_id>EC 9/25/113</org_study_id>
    <nct_id>NCT02271867</nct_id>
  </id_info>
  <brief_title>Thermal QST for Interscale Block Evaluation</brief_title>
  <official_title>Thermal Quantitative Sensory Testing as a Method to Semi-quantitatively Assess the Neurosensory Effects of 3 Local Anesthetic Solutions in an Interscalene Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Antwerp</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thermal quantitative sensory testing (QST) is a method to evaluate peripheral nerve blocks in
      a quantitative way. It assesses the neurosensory effects of local anesthetics, like nerve
      block intensity, duration, recovery, neurotoxicity, the effect of spread of local anesthetic
      solutions and the effect and the eventual neurotoxicity of adjuvants. We aimed at
      investigating, in a quantitative way, the block characteristics of 3 different commonly used
      local anesthetics on peripheral nerves through the application of thermal QST by measuring
      changes in sensory detection thresholds. Furthermore, we wanted to evaluate if QST could be
      of value for measuring gradual changes in block characteristics on the adjacent nerves at
      distance of the injection site in an US-ISB.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of sensory block</measure>
    <time_frame>24 hours after intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Degree of sensory stimulus detection threshold variation from baseline values</measure>
    <time_frame>24 hours after intervention</time_frame>
    <description>The higher the difference in detection threshold variation, the more intense the block. Measured as % change, where 100% change means no sensation on maximal QST stimulus (0°C for cold sensation and 50°C for warm sensation)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Block duration</measure>
    <time_frame>24 hours after intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of rescue medication</measure>
    <time_frame>24 hours after intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of motor block</measure>
    <time_frame>24 hours after intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Anesthetics, Local</condition>
  <condition>Nerve Block</condition>
  <arm_group>
    <arm_group_label>Levobupivacaine 0,5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Levobupivacaine 0,5% 15 ml once</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Levobupivacaine 0,5% with epinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Levobupivacaine 0,5% with 1/200000 epinephrine 15 ml once</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine 0,75%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ropivacaine 0,75% 15 ml once</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Interscalene block</intervention_name>
    <description>An ultrasound guided ISB was performed with injection aimed to block the C5-root</description>
    <arm_group_label>Levobupivacaine 0,5%</arm_group_label>
    <arm_group_label>Levobupivacaine 0,5% with epinephrine</arm_group_label>
    <arm_group_label>Ropivacaine 0,75%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients scheduled for diagnostic and therapeutic shoulder arthroscopy, with or
             without decompression technique were eligible

        Exclusion Criteria:

          -  contraindications for ISB

          -  diabetes mellitus

          -  peripheral neuropathy

          -  patients receiving chronic analgesic therapy

          -  contraindications for NSAID

          -  patients with an initial QST with abnormal values
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Antwerp University Hospital</name>
      <address>
        <city>Edegem</city>
        <state>Antwerp</state>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2014</study_first_submitted>
  <study_first_submitted_qc>October 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2014</study_first_posted>
  <last_update_submitted>October 20, 2014</last_update_submitted>
  <last_update_submitted_qc>October 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 22, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Antwerp</investigator_affiliation>
    <investigator_full_name>Ethisch Comité UZ Antwerpen</investigator_full_name>
    <investigator_title>Thermal Quantitative Sensory Testing as a method to semi-quantitatively assess the neurosensory effects of 3 local anesthetic solutions in an interscalene block</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

